Rural Cancer Survival Rates Lower Than Urban Populations

Okay,here’s a breakdown of the key details from the provided text,focusing on cancer survival ⁤disparities based on race (Black vs. White) and location (metropolitan vs.⁢ non-metropolitan areas):

Overall Findings:

* Lower Survival in⁣ Non-Metropolitan Areas: A study by the American Cancer Society (ACS) found that 5-year cancer ⁣survival rates were lower for ⁤both Black⁣ and White patients ⁣in non-metropolitan areas compared to their metropolitan counterparts.
* Disparities Exist Within ⁤Both Groups: ⁣ disparities in survival rates were observed ⁣ both overall ‍and when looking specifically at Black and White patients, and further broken down by⁤ location (urbanicity).
* ‍ Root Cause: The study suggests⁤ these disparities are largely due ⁤to inequities in access to quality‍ cancer⁣ care, linked to social determinants of health (like lack of insurance).

Specific Survival Rate Differences (Key Numbers):

* Overall ‍Survival (OS) ‍by ⁢Stage:

⁤ ⁣* ⁣ Localized: 2% ⁢lower ⁤in non-metro ⁤areas.
* ⁣ Regional: 5% lower in non-metro areas.
⁢* ⁢ Distant: 3-7% lower in non-metro‍ areas.
* Lung Cancer (Localized Stage): ⁣ The largest difference was observed here.
* ⁤ Black patients in non-metro areas: ~12% lower OS.
* White patients in non-metro areas: ~10% lower OS.
* Regional-Stage Cancers (Large Metropolitan Areas):

‍ * Black patients: 7% lower OS (61.8% vs 68.5% for White patients).
* ⁢ Distant-Stage Cancers (Large Metropolitan Areas):

* ⁢ Black patients: 7% lower OS (32.9% vs 39.8% for White patients).
* Distant-Stage Cancers (Small-Medium‍ Metropolitan Areas):

‍ ⁢ * Black patients: 5% lower OS⁢ (31.3% vs 36.1% for White patients).
* Distant-Stage Cancers (non-Metropolitan ‍areas):

* Black patients: 4% lower OS⁣ (29.5% vs 33.3% for White patients).
* Localized Prostate Cancer (metropolitan Areas):

‍⁣ * Black patients: ~1% lower OS.
* ⁣ Distant Prostate Cancer (Large Metropolitan Areas):

⁢ ‍* ‍ Black patients: ~4% lower OS.
* Localized ⁢Lung Cancer (Large Metropolitan Areas):

⁣ * ⁢ Black patients: 6% lower OS.
⁢ * Non-Metropolitan Areas: 9% lower OS.
* ‍ Regional Lung Cancer (Large Metropolitan Areas):

* Black ⁢patients: 4% lower OS.

Key ⁤Takeaway:

The study highlights a meaningful and concerning disparity in cancer survival rates based on both race and geographic location. Access to ⁤quality care, influenced by social determinants of⁢ health, appears to be a major contributing ⁢factor.

Let me know if you’d like ⁣me to elaborate on any⁣ specific ⁢aspect ⁣of⁢ this information!